Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy
Lingmin He, Annie Chan, Theodore Leng, Mark S BlumenkranzDepartment of Ophthalmology, Stanford University School of Medicine, Stanford, California, USABackground: The purpose of this study was to characterize central macular thickness and retinal volume following intravitreal injections using time d...
Saved in:
Main Authors: | He L, Chan A, Leng T, Blumenkranz MS |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/b12d293847fa482ab5773aca3ea3f75d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema
by: Mushtaq B, et al.
Published: (2014) -
Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema
by: O'Day R, et al.
Published: (2013) -
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
by: Chan A, et al.
Published: (2011) -
Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusion
by: Mimura T, et al.
Published: (2012) -
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
by: Dugel PU, et al.
Published: (2015)